z-logo
open-access-imgOpen Access
Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways
Author(s) -
Michał Janowski,
Zofia Ulańczyk,
Karolina Łuczkowska,
Anna Sobuś,
Dorota Rogińska,
Ewa PiusSadowska,
Michał Gniot,
Krzysztof Kozłowski,
Krzysztof Lewandowski,
Grzegorz Helbig,
Bogusław Machaliński,
Edyta Paczkowska
Publication year - 2022
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s371847
Subject(s) - cell cycle , downregulation and upregulation , myeloid leukemia , tyrosine kinase , cancer research , immune system , biology , cell , cell growth , bone marrow , immunology , signal transduction , medicine , gene , microbiology and biotechnology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom